Related references
Note: Only part of the references are listed.Hybrid nanoreservoirs based on dextran-capped dendritic mesoporous silica nanoparticles for CD133-targeted drug delivery
Mahsa Zahiri et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Stromal Modulation and Treatment of Metastatic Pancreatic Cancer with Local Intraperitoneal Triple miRNA/siRNA Nanotherapy
Ying Xie et al.
ACS NANO (2020)
Tumor-targeted nanoplatform for in situ oxygenation-boosted immunogenic phototherapy of colorectal cancer
Huamei He et al.
ACTA BIOMATERIALIA (2020)
MicroRNA-375-3p enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer
Fei Xu et al.
CANCER SCIENCE (2020)
Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma
Asfar S. Azmi et al.
CLINICAL CANCER RESEARCH (2020)
Mismatch Repair-Deficient Rectal Cancer and Resistance to Neoadjuvant Chemotherapy
Andrea Cercek et al.
CLINICAL CANCER RESEARCH (2020)
Evaluation of the Genotoxic and Oxidative Damage Potential of Silver Nanoparticles in Human NCM460 and HCT116 Cells
Mingxi Jia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
A multi-functionalized nanocomposite constructed by gold nanorod core with triple-layer coating to combat multidrug resistant colorectal cancer
Yajun Jiang et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2020)
Anti-EGFR-Coated Gold Nanoparticles In Vitro Carry 5-Fluorouracil to Colorectal Cancer Cells
Raquel B. Liszbinski et al.
MATERIALS (2020)
Albumin Nano-Encapsulation of Piceatannol Enhances Its Anticancer Potential in Colon Cancer Via Downregulation of Nuclear p65 and HIF-1 alpha
Alaa A. A. Aljabali et al.
CANCERS (2020)
Intracellular Delivery of Anti-SMC2 Antibodies against Cancer Stem Cells
Sara Montero et al.
PHARMACEUTICS (2020)
P-Glycoprotein Inhibition Exacerbates Paclitaxel Neurotoxicity in Neurons and Patients With Cancer
Tore B. Stage et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Nanomedicine to target multidrug resistant tumors
Elise Lepeltier et al.
DRUG RESISTANCE UPDATES (2020)
Therapeutic Potential of LNP-Mediated Delivery of miR-634 for Cancer Therapy
Kentaro Gokita et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Nanostructured toxins for the selective destruction of drug-resistant human CXCR4+ colorectal cancer stem cells
Naroa Serna et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Polysaccharide Nanoparticles Bearing HDAC Inhibitor as Nontoxic Nanocarrier for Drug Delivery
Henry Lindemann et al.
MACROMOLECULAR BIOSCIENCE (2020)
The Interplay among miRNAs, Major Cytokines, and Cancer-Related Inflammation
Chiranjib Chakraborty et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Chimeric peptide supramolecular nanoparticles for plectin-1 targeted miRNA-9 delivery in pancreatic cancer
Ying Wu et al.
THERANOSTICS (2020)
Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy
Erik Henke et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
ABC Transporters: Regulation and Association with Multidrug Resistance in Hepatocellular Carcinoma and Colorectal Carcinoma
Maria Paula Ceballos et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Pancreatic cancer stem cell proliferation is strongly inhibited by diethyldithiocarbamate-copper complex loaded into hyaluronic acid decorated liposomes
Alessandro Marengo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2019)
LncRNA CACS15 contributes to oxaliplatin resistance in colorectal cancer by positively regulating ABCC1 through sponging miR-145
Rongrong Gao et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2019)
Delivery of miR-212 by chimeric peptide-condensed supramolecular nanoparticles enhances the sensitivity of pancreatic ductal adenocarcinoma to doxorubicin
Wei Chen et al.
BIOMATERIALS (2019)
Targeting Tumor Microenvironment for Cancer Therapy
Catarina Roma-Rodrigues et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Unprecedented Behavior of (9R)-9-Hydroxystearic Acid-Loaded Keratin Nanoparticles on Cancer Cell Cycle
Alberto Busi et al.
MOLECULAR PHARMACEUTICS (2019)
P-glycoprotein Inhibitor Tariquidar Potentiates Efficacy of Astragaloside IV in Experimental Autoimmune Encephalomyelitis Mice
Wei Zhang et al.
MOLECULES (2019)
Aberrations in DNA repair pathways in cancer and therapeutic significances
Akira Motegi et al.
SEMINARS IN CANCER BIOLOGY (2019)
The role and mechanisms of action of microRNAs in cancer drug resistance
Wengong Si et al.
CLINICAL EPIGENETICS (2019)
The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven Cancers
Hamada A. Mokhlis et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Complete Regression of Advanced Pancreatic Ductal Adenocarcinomas upon Combined Inhibition of EGFR and C-RAF
Maria Teresa Blasco et al.
CANCER CELL (2019)
A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer
Guoying Jin et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
The extracellular matrix in tumor progression and metastasis
Johannes A. Eble et al.
CLINICAL & EXPERIMENTAL METASTASIS (2019)
Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer
Sheema Khan et al.
BIOMATERIALS (2019)
MiRNA-204-5p and oxaliplatin-loaded silica nanoparticles for enhanced tumor suppression effect in CD44-overexpressed colon adenocarcinoma
Hailing Yang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Gold nanoparticles regulate tight junctions and improve cetuximab effect in colon cancer cells
Fernanda Leve et al.
NANOMEDICINE (2019)
Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer
Srinivas Patnaik et al.
FRONTIERS IN PHARMACOLOGY (2019)
Epigenetically Down-Regulated Acetyltransferase PCAF Increases the Resistance of Colorectal Cancer to 5-Fluorouracil
Tong Liu et al.
NEOPLASIA (2019)
Tumor penetrating nanomedicine targeting both an oncomiR and an oncogene in pancreatic cancer
Maud-Emmanuelle Gilles et al.
Oncotarget (2019)
Improving the anticancer effect of afatinib and microRNA by using lipid polymeric nanoparticles conjugated with dual pH-responsive and targeting peptides
Shu-Ting Hong et al.
JOURNAL OF NANOBIOTECHNOLOGY (2019)
The Tumor Microenvironment in Colorectal Cancer Therapy
Leire Pedrosa et al.
CANCERS (2019)
pH-Responsive PEG-Shedding and Targeting Peptide-Modified Nanoparticles for Dual-Delivery of Irinotecan and microRNA to Enhance Tumor-Specific Therapy
Vivian Juang et al.
SMALL (2019)
PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells
Sylvie M. Noordermeer et al.
TRENDS IN CELL BIOLOGY (2019)
Development and Mechanistic Insight into the Enhanced Cytotoxic Potential of Parvifloron D Albumin Nanoparticles in EGFR-Overexpressing Pancreatic Cancer Cells
Ana Santos-Rebelo et al.
CANCERS (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Cancer stem cells (CSCs) in cancer progression and therapy
Masoud Najafi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Protein Arginine Methyltransferase 3 Enhances Chemoresistance in Pancreatic Cancer by Methylating hnRNPA1 to Increase ABCG2 Expression
Ming-Chuan Hsu et al.
CANCERS (2019)
Inflammation-responsive functional Ru nanoparticles combining a tumor-associated macrophage repolarization strategy with phototherapy for colorectal cancer therapy
Yanan Liu et al.
JOURNAL OF MATERIALS CHEMISTRY B (2019)
Layer-by-layer nanoparticles for novel delivery of cisplatin and PARP inhibitors for platinum-based drug resistance therapy in ovarian cancer
Lawrence B. Mensah et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2019)
Development of EGFR-targeted evodiamine nanoparticles for the treatment of colorectal cancer
Chunpu Li et al.
BIOMATERIALS SCIENCE (2019)
A nano-liposome formulation of the PARP inhibitor Talazoparib enhances treatment efficacy and modulates immune cell populations in mammary tumors of BRCA-deficient mice
Di Zhang et al.
THERANOSTICS (2019)
Bifunctional liposomes reduce the chemotherapy resistance of doxorubicin induced by reactive oxygen species
Lei Xu et al.
BIOMATERIALS SCIENCE (2019)
Repurposing of Cetuximab in antibody-directed chemotherapy-loaded nanoparticles in EGFR therapy-resistant pancreatic tumours
William J. McDaid et al.
NANOSCALE (2019)
Gold Nanoparticles sensitize pancreatic cancer cells to gemcitabine
Yanyan Huai et al.
CELL STRESS (2019)
Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors
Prashanth Rawla et al.
GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY (2019)
Drug resistance and combating drug resistance in cancer
Xuan Wang et al.
CANCER DRUG RESISTANCE (2019)
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Deepali Waghray et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Emerging functions of the EGFR in cancer
Sara Sigismund et al.
MOLECULAR ONCOLOGY (2018)
CHK1 inhibition sensitizes pancreatic cancer cells to gemcitabine via promoting CDK-dependent DNA damage and ribonucleotide reductase downregulation
Min Liang et al.
ONCOLOGY REPORTS (2018)
Epigenomics alternations and dynamic transcriptional changes in responses to 5-fluorouracil stimulation reveal mechanisms of acquired drug resistance of colorectal cancer cells
Y. Shen et al.
PHARMACOGENOMICS JOURNAL (2018)
Silver nanoparticles of different sizes induce a mixed type of programmed cell death in human pancreatic ductal adenocarcinoma
Ewelina Zielinska et al.
ONCOTARGET (2018)
Ultrasound Triggered Conversion of Porphyrin/Camptothecin-Fluoroxyuridine Triad Microbubbles into Nanoparticles Overcomes Multidrug Resistance in Colorectal Cancer
Min Chen et al.
ACS NANO (2018)
Histone Deacetylase Inhibitor (HDACi) Conjugated Polycaprolactone for Combination Cancer Therapy
Ruvanthi N. Kularatne et al.
BIOMACROMOLECULES (2018)
Tissue-Penetrating, Hypoxia-Responsive Echogenic Polymersomes For Drug Delivery To Solid Tumors
Prajakta Kulkarni et al.
CHEMISTRY-A EUROPEAN JOURNAL (2018)
PARP Inhibitor Drugs in the Treatment of Breast, Ovarian, Prostate and Pancreatic Cancers: An Update of Clinical Trials
Dalia Kamel et al.
CURRENT DRUG TARGETS (2018)
DNA damage response and repair in colorectal cancer: Defects, regulation and therapeutic implications
Mohammad Mirza-Aghazadeh-Attari et al.
DNA REPAIR (2018)
Apoptosis: A Target for Anticancer Therapy
Claire M. Pfeffer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy
Yang Li et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Fluorescent Nanodiamonds are Efficient, Easy-to-Use Cyto-Compatible Vehicles for Monitored Delivery of Non-Coding Regulatory RNAs
Sonja Lukowski et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2018)
Hypoxia-inducible bidirectional shRNA expression vector delivery using PEI/chitosan-TBA copolymers for colorectal Cancer gene therapy
Bita Javan et al.
LIFE SCIENCES (2018)
Polymeric chitosan-glycolipid nanocarriers for an effective delivery of marine carotenoid fucoxanthin for induction of apoptosis in human colon Check for cancer cells (Caco-2 cells)
Hindupur Ravi et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2018)
Facile Deposition of Manganese Dioxide to Albumin-Bound Paclitaxel Nanoparticles for Modulation of Hypoxic Tumor Microenvironment To Improve Chemoradiation Therapy
Lingtong Meng et al.
MOLECULAR PHARMACEUTICS (2018)
Targeted delivery of miRNA-204-5p by PEGylated polymer nanoparticles for colon cancer therapy
Bo Zheng et al.
NANOMEDICINE (2018)
Tumor associated macrophages and angiogenesis dual-recognizable nanoparticles for enhanced cancer chemotherapy
Duo Cao et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
DNA mismatch repair in cancer
Marina Baretti et al.
PHARMACOLOGY & THERAPEUTICS (2018)
YAP-dependent ubiquitination and degradation of β-catenin mediates inhibition of Wnt signalling induced by Physalin F in colorectal cancer
Chen Chen et al.
CELL DEATH & DISEASE (2018)
Dynamic quantitative detection of ABC transporter family promoter methylation by MS-HRM for predicting MDR in pancreatic cancer
Lie Yao et al.
ONCOLOGY LETTERS (2018)
Black TiO2-based nanoprobes for T1-weighted MRI-guided photothermal therapy in CD133 high expressed pancreatic cancer stem-like cells
Siqi Wang et al.
BIOMATERIALS SCIENCE (2018)
pH- and GSH-Sensitive Hyaluronic Acid-MP Conjugate Micelles for Intracellular Delivery of Doxorubicin to Colon Cancer Cells and Cancer Stem Cells
Tilahun Ayane Debele et al.
BIOMACROMOLECULES (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Overcoming P-Glycoprotein-Mediated Multidrug Resistance in Colorectal Cancer: Potential Reversal Agents among Herbal Medicines
Gayoung Lee et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2018)
Novel 4-in-1 strategy to combat colon cancer, drug resistance and cancer relapse utilizing functionalized bioinspiring lignin nanoparticle
Lubna Siddiqui et al.
MEDICAL HYPOTHESES (2018)
Synthetically Lethal BMN 673 (Talazoparib) Loaded Solid Lipid Nanoparticles for BRCA1 Mutant Triple Negative Breast Cancer
Gamze Guney Eskiler et al.
PHARMACEUTICAL RESEARCH (2018)
ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: what is the way forward?
Aleksandra Adamska et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Reversal of pancreatic desmoplasia by re-educating stellate cells with a tumour microenvironment-activated nanosystem
Xuexiang Han et al.
NATURE COMMUNICATIONS (2018)
Epidermal Growth Factor Receptor-Targeting Peptide Nanoparticles Simultaneously Deliver Gemcitabine and Olaparib To Treat Pancreatic Cancer with Breast Cancer 2 (BRCA2) Mutation
Chong Du et al.
ACS NANO (2018)
Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer
Zeting Yuan et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Structural and functional aspects of P-glycoprotein and its inhibitors
Shirin Mollazadeh et al.
LIFE SCIENCES (2018)
MicroRNA therapeutics: design of single-stranded miR-216b mimics to target KRAS in pancreatic cancer cells
Annalisa Ferino et al.
RNA BIOLOGY (2018)
Overcoming Drug Resistance in Colon Cancer by Aptamer-Mediated Targeted Co-Delivery of Drug and siRNA Using Grapefruit-Derived Nanovectors
Wei Yan et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Impact of Breast Cancer Resistance Protein Expression on the In Vitro Efficacy of Anticancer Drugs in Pancreatic Cancer Cell Lines
Ikumi Washio et al.
DRUG METABOLISM AND DISPOSITION (2018)
Knockdown of Long Non-Coding RNA XIST Inhibited Doxorubicin Resistance in Colorectal Cancer by Upregulation of miR-124 and Downregulation of SGK1
Jia Zhu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Germline and Somatic DNA Damage Repair Gene Mutations and Overall Survival in Metastatic Pancreatic Adenocarcinoma Patients Treated with FOLFIRINOX
Amikar Sehdev et al.
CLINICAL CANCER RESEARCH (2018)
Restitution of Tumor Suppressor MicroRNA-145 Using Magnetic Nanoformulation for Pancreatic Cancer Therapy
Saini Setua et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2017)
The role of p53 in cancer drug resistance and targeted chemotherapy
Karin Hientz et al.
ONCOTARGET (2017)
Mechanisms of DNA Damage, Repair, and Mutagenesis
Nimrat Chatterjee et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2017)
Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer
Prashant Joshi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
GPR55 receptor antagonist decreases glycolytic activity in PANC-1 pancreatic cancer cell line and tumor xenografts
Michel Bernier et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Molecular-Targeted Therapies for Epidermal Growth Factor Receptor and Its Resistance Mechanisms
Toshimitsu Yamaoka et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Drug Resistance Driven by Cancer Stem Cells and Their Niche
Marta Prieto-Vila et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Selection and optimization of nano-formulation of P-glycoprotein inhibitor for reversal of doxorubicin resistance in COLO205 cells
Tapan K. Dash et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2017)
Photo-catalytic, anti-bacterial, and anti-cancer properties of phyto-mediated synthesis of silver nanoparticles from Artemisia tournefortiana Rchb extract
Fahimeh Baghbani-Arani et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2017)
Nanoformulation of Olaparib Amplifies PARP Inhibition and Sensitizes PTEN/TP53-Deficient Prostate Cancer to Radiation
Anne L. van de Ven et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Photodynamic Therapy Using Photosensitizer-Encapsulated Polymeric Nanoparticle to Overcome ATP-Binding Cassette Transporter Subfamily G2 Function in Pancreatic Cancer
Yoon Jin Roh et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Effect of partial PEGylation on particle uptake by macrophages
Lucero Sanchez et al.
NANOSCALE (2017)
The multifaceted roles of PARP1 in DNA repair and chromatin remodelling
Arnab Ray Chaudhuri et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Bufalin reverses ABCB1-mediated drug resistance in colorectal cancer
Ze-Ting Yuan et al.
ONCOTARGET (2017)
Multifunctional Nucleus-targeting Nanoparticles with Ultra-high Gene Transfection Efficiency for In Vivo Gene Therapy
Ling Li et al.
THERANOSTICS (2017)
Investigation of Copper Cysteamine Nanoparticles as a New Type of Radiosensitiers for Colorectal Carcinoma Treatment
Zhipeng Liu et al.
SCIENTIFIC REPORTS (2017)
The involvement of lncRNAs in the development and progression of pancreatic cancer
Li Duguang et al.
CANCER BIOLOGY & THERAPY (2017)
SN38-PEG-PLGA-verapamil nanoparticles inhibit proliferation and downregulate drug transporter ABCG2 gene expression in colorectal cancer cells
Zahra Nagheh et al.
PROGRESS IN BIOMATERIALS (2017)
Oxygen-Self-Produced Nanoplatform for Relieving Hypoxia and Breaking Resistance to Sonodynamic Treatment of Pancreatic Cancer
Jie Chen et al.
ACS NANO (2017)
Aberrant DNA Methylation in Colorectal Cancer: What Should We Target?
Janson W. T. Tse et al.
TRENDS IN CANCER (2017)
Cromolyn chitosan nanoparticles as a novel protective approach for colorectal cancer
Tarek K. Motawi et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
Co-delivery of microRNA-21 antisense oligonucleotides and gemcitabine using nanomedicine for pancreatic cancer therapy
Yaqing Li et al.
CANCER SCIENCE (2017)
In vitro evaluation of cytotoxicity, possible alteration of apoptotic regulatory proteins, and antibacterial activity of synthesized copper oxide nanoparticles
Shahanavaj Khan et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2017)
Photodynamic Therapy Synergizes with Irinotecan to Overcome Compensatory Mechanisms and Improve Treatment Outcomes in Pancreatic Cancer
Huang-Chiao Huang et al.
CANCER RESEARCH (2016)
Molecular mechanisms of drug resistance and its reversal in cancer
Melis Kartal-Yandim et al.
CRITICAL REVIEWS IN BIOTECHNOLOGY (2016)
Magnetic gold nanoparticle-mediated small interference RNA silencing Bag-1 gene for colon cancer therapy
Wenbai Huang et al.
ONCOLOGY REPORTS (2016)
Nuclear-targeting TAT-PEG-Asp8-doxorubicin polymeric nanoassembly to overcome drug-resistant colon cancer
Zhen-zhen Pan et al.
ACTA PHARMACOLOGICA SINICA (2016)
Toward a Better Understanding of the Complexity of Cancer Drug Resistance
Michael M. Gottesman et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56 (2016)
Tungsten Oxide Nanoplates; the Novelty in Targeting Metalloproteinase-7 Gene in Both Cervix and Colon Cancer Cells
Abdelrahman M. Yassin et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2016)
A theranostic micelleplex co-delivering SN-38 and VEGF siRNA for colorectal cancer therapy
Shin-Yu Lee et al.
BIOMATERIALS (2016)
NF-κB decoy polyplexes decrease P-glycoprotein-mediated multidrug resistance in colorectal cancer cells
N. H. Abd Ellah et al.
CANCER GENE THERAPY (2016)
Cationic microRNA-delivering nanocarriers for efficient treatment of colon carcinoma in xenograft model
G. Liang et al.
GENE THERAPY (2016)
Styrene maleic acid-encapsulated paclitaxel micelles: antitumor activity and toxicity studies following oral administration in a murine orthotopic colon cancer model
Neha N. Parayath et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
EGFR-targeted gelatin nanoparticles for systemic administration of gemcitabine in an orthotopic pancreatic cancer model
Amit Singh et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
Phase II Study of Olaparib (AZD-2281) After Standard Systemic Therapies for Disseminated Colorectal Cancer
Lawrence Leichman et al.
ONCOLOGIST (2016)
Selective GPR55 antagonism reduces chemoresistance in cancer cells
Nagendra S. Singh et al.
PHARMACOLOGICAL RESEARCH (2016)
Mismatch Repair and Colon Cancer: Mechanisms and Therapies Explored
Stephen K. H. Li et al.
TRENDS IN MOLECULAR MEDICINE (2016)
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer
Beth O. van Emburgh et al.
NATURE COMMUNICATIONS (2016)
The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer
Mei-Ren Pan et al.
ONCOTARGET (2016)
LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p
Zehua Bian et al.
SCIENTIFIC REPORTS (2016)
Arsenite-loaded nanoparticles inhibit PARP-1 to overcome multidrug resistance in hepatocellular carcinoma cells
Hanyu Liu et al.
SCIENTIFIC REPORTS (2016)
Gd-Metallofullerenol Nanomaterial Suppresses Pancreatic Cancer Metastasis by Inhibiting the Interaction of Histone Deacetylase 1 and Metastasis-Associated Protein 1
Yuanming Pan et al.
ACS NANO (2015)
Nanoparticle formulations of histone deacetylase inhibitors for effective chemoradiotherapy in solid tumors
Edina C. Wang et al.
BIOMATERIALS (2015)
Inhibition of MDR1 gene expression and enhancing cellular uptake for effective colon cancer treatment using dual-surface-functionalized nanoparticles
Bo Xiao et al.
BIOMATERIALS (2015)
Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer
Sabrina Arena et al.
CLINICAL CANCER RESEARCH (2015)
The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade
Rishil J. Kathawala et al.
DRUG RESISTANCE UPDATES (2015)
P-glycoprotein and membrane roles in multidrug resistance
Ricardo J. Ferreira et al.
FUTURE MEDICINAL CHEMISTRY (2015)
Hyaluronan coated liposomes as the intravenous platform for delivery of imatinib mesylate in MDR colon cancer
Lalit Mohan Negi et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2015)
Inhibition of colon cancer cell growth by nanoemulsion carrying gold nanoparticles and lycopene
Rwei-Fen S. Huang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2015)
The genomic landscape of response to EGFR blockade in colorectal cancer
Andrea Bertotti et al.
NATURE (2015)
Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy
Renata Silva et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Anti-proliferative Activity of Nano-Formulated Phenolato Titanium(IV) Complexes Against Cancer Cells
Sigalit Meker et al.
CHEMMEDCHEM (2014)
Surface engineered nanostructured lipid carriers for targeting MDR tumor: Part I. Synthesis, characterization and in vitro investigation
Lalit Mohan Negi et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2014)
ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
Young Hee Choi et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
A novel approach to overcome multidrug resistance: Utilization of P-gp mediated efflux of paclitaxel to attack neighboring vascular endothelial cells in tumors
Yuta Yoshizawa et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Liposomal Nitrooxy-Doxorubicin: One Step over Caelyx in Drug-Resistant Human Cancer Cells
Isabella Pedrini et al.
MOLECULAR PHARMACEUTICS (2014)
Apoptotic cascade inspired lipid nanovesicles show synergism with encapsulated paclitaxel in chemoresistant colon carcinoma
Nitin Joshi et al.
NANOMEDICINE (2014)
Reversing Multidrug Resistance in Caco-2 by Silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL Using Liposomal Antisense Oligonucleotides
Yu-Li Lo et al.
PLOS ONE (2014)
Selection of pancreatic cancer cell-binding landscape phages and their use in development of anticancer nanomedicines
Deepa Bedi et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2014)
Epigenetics and pancreatic cancer: Pathophysiology and novel treatment aspects
Daniel Neureiter et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
The Roles of MRP2, MRP3, OATP1B1, and OATP1B3 in Conjugated Hyperbilirubinemia
Dietrich Keppler
DRUG METABOLISM AND DISPOSITION (2014)
Suppression of pancreatic tumor growth by targeted arsenic delivery with anti-CD44v6 single chain antibody conjugated nanoparticles
Chenchen Qian et al.
BIOMATERIALS (2013)
Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer
Fan Bai et al.
BIOMATERIALS (2013)
Overcoming multidrug resistance using liposomal epirubicin and antisense oligonucleotides targeting pump and nonpump resistances in vitro and in vivo
Yu-Li Lo et al.
BIOMEDICINE & PHARMACOTHERAPY (2013)
Influence of MLH1 on colon cancer sensitivity to poly(ADP-ribose) polymerase inhibitor combined with irinotecan
Lucio Tentori et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Novel Curcumin-Loaded Magnetic Nanoparticles for Pancreatic Cancer Treatment
Murali M. Yallapu et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Silver-based nanoparticles induce apoptosis in human colon cancer cells mediated through p53
Shakti Ranjan Satapathy et al.
NANOMEDICINE (2013)
The quest to overcome resistance to EGFR-targeted therapies in cancer
Curtis R. Chong et al.
NATURE MEDICINE (2013)
Mechanistic studies of Gemcitabine-loaded nanoplatforms in resistant pancreatic cancer cells
Anne-Laure Papa et al.
BMC CANCER (2012)
The influence of mass of [11C]-laniquidar and [11C]-N-desmethyl-loperamide on P-glycoprotein blockage at the blood-brain barrier
Lieselotte Moerman et al.
NUCLEAR MEDICINE AND BIOLOGY (2012)
Multidrug resistance associated proteins in multidrug resistance
Kamlesh Sodani et al.
CHINESE JOURNAL OF CANCER (2012)
Study of the enhanced anticancer efficacy of gambogic acid on Capan-1 pancreatic cancer cells when mediated via magnetic Fe3O4 nanoparticles
Cailian Wang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2011)
Liposome-Encapsulated Doxorubicin Reverses Drug Resistance by Inhibiting P-Glycoprotein in Human Cancer Cells
Chiara Riganti et al.
MOLECULAR PHARMACEUTICS (2011)
Designing Nanoconjugates to Effectively Target Pancreatic Cancer Cells In Vitro and In Vivo
Jameel Ahmad Khan et al.
PLOS ONE (2011)
Nanoparticle-delivered VEGF-silencing cassette and suicide gene expression cassettes inhibit colon carcinoma growth in vitro and in vivo
Aimin Leng et al.
TUMOR BIOLOGY (2011)
Therapeutic targeting of epidermal growth factor receptor in human cancer: successes and limitations
Jill Wykosky et al.
Chinese Journal of Cancer (2011)
Polycationic Nanodrug Covered with Hyaluronic Acid for Treatment of P-Glycoprotein Overexpressing Cancer Cells
Hyeona Yim et al.
BIOMACROMOLECULES (2010)
Signaling gene cascade in silver nanoparticle induced apoptosis
P. Gopinath et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2010)
Chemical Composition of Five Commercial Gynostemma pentaphyllum Samples and Their Radical Scavenging, Antiproliferative, and Anti-inflammatory Properties
Zhuohong Xie et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2010)
Programmed cell death and cancer
Y. Sun et al.
POSTGRADUATE MEDICAL JOURNAL (2009)
Hepatic drug transporters and nuclear receptors: Regulation by therapeutic agents
Aldo D. Mottino et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Mechanisms and strategies to overcome multiple drug resistance in cancer
Tomris Ozben
FEBS LETTERS (2006)
Molecular mechanisms of drug resistance
DB Longley et al.
JOURNAL OF PATHOLOGY (2005)
The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability
LMS Chan et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
The MRP family of drug efflux pumps
GD Kruh et al.
ONCOGENE (2003)
Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs
F Ciardiello et al.
EUROPEAN JOURNAL OF CANCER (2003)
The role of ABC transporters in clinical practice
GD Leonard et al.
ONCOLOGIST (2003)
Expression of the BCRP gene (ABCG2/MXR/ABCP) in childhood acute lymphoblastic leukaemia
A Sauerbrey et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Share Paper
